...
首页> 外文期刊>International Journal of Nanomedicine >Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole
【24h】

Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole

机译:低毒性N-Caprinoyl-N-三甲基乙基壳聚糖作为Osthole的自组装胶束载体的合成与表征

获取原文
           

摘要

Abstract: Novel amphiphilic chitosan derivatives (N-caprinoyl-N-trimethyl chitosan [CA-TMC]) were synthesized by grafting the hydrophobic moiety caprinoyl (CA) and hydrophilic moiety trimethyl chitosan to prepare carriers with good compatibility for poorly soluble drugs. Based on self-assembly, CA-TMC can form micelles with sizes ranging from 136 nm to 212 nm. The critical aggregation concentration increased from 0.6 mg · L-1 to 88 mg · L-1 with decrease in the degree of CA substitution. Osthole (OST) could be easily encapsulated into the CA-TMC micelles. The highest entrapment efficiency and drug loading of OST-loaded CA-TMC micelles(OST/CA-TMC) were 79.1% and 19.1%, respectively. The antitumor efficacy results show that OST/CA-TMC micelles have significant antitumor activity on Hela and MCF-7 cells, with a 50% of cell growth inhibition (IC50) of 35.8 and 46.7 μg · mL-1, respectively. Cell apoptosis was the main effect on cell death of Hela and MCF-7 cells after OST administration. The blank micelles did not affect apoptosis or cell death of Hela and MCF-7 cells. The fluorescence imaging results indicated that OST/CA-TMC micelles could be easily uptaken by Hela and MCF-7 cells and could localize in the cell nuclei. These findings suggest that CA-TMC micelles are promising carriers for OST delivery in cancer therapy.
机译:摘要:通过嫁接疏水部分辣椒蛋白酶(CA)和亲水部分三甲基壳聚糖来制备具有良好可溶性药物的载流子,通过接枝疏水部分己酰基(CA)和亲水部分的载体来合成新的两亲型壳聚糖衍生物(N-Caprinoyl-N-三甲基甲基壳聚糖[Ca-TMC])。基于自组装,CA-TMC可以形成尺寸范围为136nm至212nm的胶束。临界聚集浓度从0.6mg·1-1至88mg·l-1增加,随着Ca取代度的降低而降低。 Osthole(OST)可以很容易地封装到CA-TMC胶束中。 OST负载的CA-TMC胶束(OST / CA-TMC)的最高夹带效率和药物负载分别为79.1%和19.1%。抗肿瘤功效结果表明,OST / CA-TMC胶束在Hela和MCF-7细胞上具有显着的抗肿瘤活性,分别为35.8和46.7μg·mL-1的50%的细胞生长抑制(IC 50)。细胞凋亡是OST给药后Hela和MCF-7细胞细胞死亡的主要影响。空白胶束不影响HeLa和MCF-7细胞的细胞凋亡或细胞死亡。荧光成像结果表明,OST / CA-TMC胶束可以通过HELA和MCF-7细胞容易地膨胀,并且可以在细胞核中定位。这些研究结果表明CA-TMC胶束是癌症治疗中OST递送的承诺载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号